COALESCE
Device
NuVasive, Inc.
Total Payments
$981,684
Transactions
254
Doctors
120
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $16,114 | 17 | 6 |
| 2023 | $119,398 | 18 | 11 |
| 2022 | $226,170 | 26 | 10 |
| 2021 | $109,806 | 35 | 20 |
| 2020 | $154,086 | 27 | 19 |
| 2019 | $345,903 | 43 | 28 |
| 2018 | $10,207 | 88 | 66 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $913,468 | 71 | 93.1% |
| Unspecified | $55,304 | 13 | 5.6% |
| Food and Beverage | $6,504 | 151 | 0.7% |
| Travel and Lodging | $3,208 | 18 | 0.3% |
| Consulting Fee | $3,200 | 1 | 0.3% |
Payments by Type
General
$926,380
241 transactions
Research
$55,304
13 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $32,943 | 0 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $18,750 | 0 |
| NUVA.LIB1119: A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $3,611 | 0 |
Top Doctors Receiving Payments for COALESCE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Orthopaedic Surgery of the Spine | Chicago, IL | $464,174 | 8 |
| , MD | Orthopaedic Surgery | Chestnut Hill, MA | $176,221 | 17 |
| , MD | Neurological Surgery | Metairie, LA | $108,660 | 21 |
| , MD | Orthopaedic Surgery of the Spine | Raleigh, NC | $93,012 | 11 |
| , M.D | Orthopaedic Surgery | Hinsdale, IL | $56,918 | 21 |
| Unknown | — | Olympia, WA | $55,304 | 13 |
| , MD | Neurological Surgery | New York, NY | $15,705 | 1 |
| , MD | Orthopaedic Surgery | Thousand Oaks, CA | $3,200 | 1 |
| , MD | Orthopaedic Surgery | Fishers, IN | $979.47 | 4 |
| Adam Kanter | Neurological Surgery | Pittsburgh, PA | $501.48 | 2 |
| , M.D | Orthopaedic Surgery of the Spine | Spokane, WA | $499.36 | 3 |
| , MD | Neurological Surgery | Pomona, CA | $449.74 | 4 |
| , MD | Orthopaedic Surgery | Port Saint Lucie, FL | $412.71 | 3 |
| , M.D | Orthopaedic Surgery of the Spine | Aurora, CO | $226.28 | 3 |
| , MD | Orthopaedic Surgery of the Spine | Park Ridge, IL | $176.23 | 2 |
| , M.D | Neurological Surgery | New York, NY | $173.99 | 1 |
| , MD | Orthopaedic Surgery of the Spine | New York, NY | $172.98 | 1 |
| , MD | Orthopaedic Surgery | Corpus Christi, TX | $150.26 | 1 |
| , M.D | Physician Assistant | Marietta, GA | $140.49 | 2 |
| , MD | Orthopaedic Surgery of the Spine | West Harrison, NY | $139.34 | 1 |
| , M.D | Orthopaedic Surgery of the Spine | New York, NY | $132.89 | 1 |
| , M.D | Neurological Surgery | Pocatello, ID | $125.22 | 2 |
| , MD | Neurological Surgery | Charlottesville, VA | $122.52 | 1 |
| , MD | Orthopaedic Surgery of the Spine | Augusta, GA | $122.29 | 2 |
| , MD | Orthopaedic Surgery | Danbury, CT | $120.58 | 1 |
Ad
Manufacturing Companies
- NuVasive, Inc. $965,570
- Globus Medical, Inc. $16,114
Product Information
- Type Device
- Total Payments $981,684
- Total Doctors 120
- Transactions 254
About COALESCE
COALESCE is a device associated with $981,684 in payments to 120 healthcare providers, recorded across 254 transactions in the CMS Open Payments database. The primary manufacturer is NuVasive, Inc..
Payment data is available from 2018 to 2024. In 2024, $16,114 was paid across 17 transactions to 6 doctors.
The most common payment nature for COALESCE is "Royalty or License" ($913,468, 93.1% of total).
COALESCE is associated with 3 research studies, including "A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine" ($32,943).